Literature DB >> 17101972

Adrenergic modulation of NMDA receptors in prefrontal cortex is differentially regulated by RGS proteins and spinophilin.

Wenhua Liu1, Eunice Y Yuen, Patrick B Allen, Jian Feng, Paul Greengard, Zhen Yan.   

Abstract

The noradrenergic system in the prefrontal cortex (PFC) is involved in many physiological and psychological processes, including working memory and mood control. To understand the functions of the noradrenergic system, we examined the regulation of NMDA receptors (NMDARs), key players in cognition and emotion, by alpha1- and alpha2-adrenergic receptors (alpha1-ARs, alpha2-ARs) in PFC pyramidal neurons. Applying norepinephrine or a norepinephrine transporter inhibitor reduced the amplitude but not paired-pulse ratio of NMDAR-mediated excitatory postsynaptic currents (EPSC) in PFC slices. Specific alpha1-AR or alpha2-AR agonists also decreased NMDAR-EPSC amplitude and whole-cell NMDAR current amplitude in dissociated PFC neurons. The alpha1-AR effect depended on the phospholipase C-inositol 1,4,5-trisphosphate-Ca(2+) pathway, whereas the alpha2-AR effect depended on protein kinase A and the microtubule-based transport of NMDARs that is regulated by ERK signaling. Furthermore, two members of the RGS family, RGS2 and RGS4, were found to down-regulate the effect of alpha1-AR on NMDAR currents, whereas only RGS4 was involved in inhibiting alpha2-AR regulation of NMDAR currents. The regulating effects of RGS2/4 on alpha1-AR signaling were lost in mutant mice lacking spinophilin, which binds several RGS members and G protein-coupled receptors, whereas the effect of RGS4 on alpha2-AR signaling was not altered in spinophilin-knockout mice. Our work suggests that activation of alpha1-ARs or alpha2-ARs suppresses NMDAR currents in PFC neurons by distinct mechanisms. The effect of alpha1-ARs is modified by RGS2/4 that are recruited to the receptor complex by spinophilin, whereas the effect of alpha2-ARs is modified by RGS4 independent of spinophilin.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17101972      PMCID: PMC1838752          DOI: 10.1073/pnas.0604560103

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  41 in total

Review 1.  Divergence of RGS proteins: evidence for the existence of six mammalian RGS subfamilies.

Authors:  B Zheng; L De Vries; M Gist Farquhar
Journal:  Trends Biochem Sci       Date:  1999-11       Impact factor: 13.807

Review 2.  G-protein-coupled receptors, tyrosine kinases and neurotransmission.

Authors:  Urs Gerber
Journal:  Neuropharmacology       Date:  2002-04       Impact factor: 5.250

Review 3.  The regulator of G protein signaling family.

Authors:  L De Vries; B Zheng; T Fischer; E Elenko; M G Farquhar
Journal:  Annu Rev Pharmacol Toxicol       Date:  2000       Impact factor: 13.820

4.  Increased noradrenergic activity in prefrontal cortex slices of an animal model for attention-deficit hyperactivity disorder--the spontaneously hypertensive rat.

Authors:  V Russell; S Allie; T Wiggins
Journal:  Behav Brain Res       Date:  2000-12-20       Impact factor: 3.332

Review 5.  The functional anatomy, neurochemistry, and pharmacology of anxiety.

Authors:  P T Ninan
Journal:  J Clin Psychiatry       Date:  1999       Impact factor: 4.384

6.  Dopamine D1 activation potentiates striatal NMDA receptors by tyrosine phosphorylation-dependent subunit trafficking.

Authors:  Penelope J Hallett; Robert Spoelgen; Bradley T Hyman; David G Standaert; Anthone W Dunah
Journal:  J Neurosci       Date:  2006-04-26       Impact factor: 6.167

Review 7.  Glutamatergic mechanisms in schizophrenia.

Authors:  Guochuan Tsai; Joseph T Coyle
Journal:  Annu Rev Pharmacol Toxicol       Date:  2002       Impact factor: 13.820

8.  Agonist-regulated Interaction between alpha2-adrenergic receptors and spinophilin.

Authors:  J G Richman; A E Brady; Q Wang; J L Hensel; R J Colbran; L E Limbird
Journal:  J Biol Chem       Date:  2001-01-11       Impact factor: 5.157

9.  The alpha(2a)-adrenergic receptor plays a protective role in mouse behavioral models of depression and anxiety.

Authors:  N L Schramm; M P McDonald; L E Limbird
Journal:  J Neurosci       Date:  2001-07-01       Impact factor: 6.167

10.  Spinophilin regulates the formation and function of dendritic spines.

Authors:  J Feng; Z Yan; A Ferreira; K Tomizawa; J A Liauw; M Zhuo; P B Allen; C C Ouimet; P Greengard
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-01       Impact factor: 11.205

View more
  36 in total

1.  The α2A -adrenoceptor suppresses excitatory synaptic transmission to both excitatory and inhibitory neurons in layer 4 barrel cortex.

Authors:  Minoru Ohshima; Chiaki Itami; Fumitaka Kimura
Journal:  J Physiol       Date:  2017-10-25       Impact factor: 5.182

Review 2.  Alcohol and the prefrontal cortex.

Authors:  Kenneth Abernathy; L Judson Chandler; John J Woodward
Journal:  Int Rev Neurobiol       Date:  2010       Impact factor: 3.230

Review 3.  NR2B subunit in the prefrontal cortex: A double-edged sword for working memory function and psychiatric disorders.

Authors:  Sarah A Monaco; Yelena Gulchina; Wen-Jun Gao
Journal:  Neurosci Biobehav Rev       Date:  2015-07-02       Impact factor: 8.989

4.  Glutamate Receptor Modulation Is Restricted to Synaptic Microdomains.

Authors:  Gyorgy Lur; Michael J Higley
Journal:  Cell Rep       Date:  2015-07-02       Impact factor: 9.423

5.  RACK1 is involved in β-amyloid impairment of muscarinic regulation of GABAergic transmission.

Authors:  Wenhua Liu; Fei Dou; Jian Feng; Zhen Yan
Journal:  Neurobiol Aging       Date:  2009-12-01       Impact factor: 4.673

Review 6.  Roles for Regulator of G Protein Signaling Proteins in Synaptic Signaling and Plasticity.

Authors:  Kyle J Gerber; Katherine E Squires; John R Hepler
Journal:  Mol Pharmacol       Date:  2015-12-11       Impact factor: 4.436

7.  Neuroplasticity regulation by noradrenaline in mammalian brain.

Authors:  Aude Marzo; Jing Bai; Satoru Otani
Journal:  Curr Neuropharmacol       Date:  2009-12       Impact factor: 7.363

Review 8.  Molecular mechanisms underlying synergistic effects of SSRI-antipsychotic augmentation in treatment of negative symptoms in schizophrenia.

Authors:  Yael Chertkow; Orly Weinreb; Moussa B H Youdim; Henry Silver
Journal:  J Neural Transm (Vienna)       Date:  2009-07-04       Impact factor: 3.575

9.  Selective suppression of excitatory synapses on GABAergic interneurons by norepinephrine in juvenile rat prefrontal cortical microcircuitry.

Authors:  H-X Wang; B D Waterhouse; W-J Gao
Journal:  Neuroscience       Date:  2013-05-14       Impact factor: 3.590

10.  Suppression of immunoglobulin E-mediated allergic responses by regulator of G protein signaling 13.

Authors:  Geetanjali Bansal; Zhihui Xie; Sudhir Rao; Karl H Nocka; Kirk M Druey
Journal:  Nat Immunol       Date:  2007-11-18       Impact factor: 25.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.